NWBO OTC
Northwest Biotherapeutics, Inc.
1W: -6.2%
1M: -11.4%
3M: -20.1%
YTD: -41.1%
1Y: -39.7%
3Y: -81.9%
5Y: -89.7%
$0.15
-0.00 (-1.51%)
Weekly Expected Move ±5.5%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$2M
Revenue
+98.6% YoY
$-38M
Net Income
+54.3% YoY
$-48M
Free Cash Flow
-7.2% YoY
-5.6%
Gross Margin
-1438.0%
Op. Margin
-1142.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE55.8%
ROA-71.5%
ROIC-188.7%
Valuation
P/E-6.0
P/B-7.1
EV/EBITDA-6.3
Leverage
Debt/Equity-1.62
Current Ratio0.04
Interest Cov.-5.4x
Quality Scores
Piotroski F3/9
Altman Z-29.60
Beneish M-3.64